Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
The Dow Jones closed higher by over 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Superior Drilling Products
- The Trade: Superior Drilling Products Inc (NYSE:SDPI) 10% owner Star Equity Holdings Inc bought a total of 79,837 shares at an average price of $0.97. To acquire these shares, it cost around $77.49 thousand.
- What’s Happening: Superior Drilling sees FY22 revenue of $19 million to $19.2 million.
- What Superior Drilling Products Does: Superior Drilling Products Inc is engaged in providing equipment and services to the oil and gas industry.
GlycoMimetics
- The Trade: GlycoMimetics Inc (NASDAQ:GLYC) 10% owner Invus Public Equities Advisors, LLC acquired a total 400,000 shares at an average price of $1.78. The insider spent around $712.25 thousand to buy those shares.
- What’s Happening: GlycoMimetics announced since the start of Q4 2022, it sold 11,776,784 shares of common stock under its existing at-the-market sales facility, raising a total of $32.9 million in net proceeds.
- What GlycoMimetics Does: GlycoMimetics Inc is a clinical stage biotechnology company.
Check This Out: Top 5 Energy Stocks Which Could Rescue Your Portfolio This Month
VolitionRX
- The Trade: VolitionRX Ltd (NYSE:VNRX) Director Guy Archibald Innes acquired a total of 234,000 shares at an average price of $1.75. To acquire these shares, it cost around $409.5 thousand.
- What’s Happening: VolitionRX announced pricing of a $4.3 million share common stock offering at $1.75 per share.
- What VolitionRX Does: VolitionRX Ltd is a us-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers.
Don’t forget to check out our premarket coverage here
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.